SIMBRINZA 1%/0.2% brinzolamide 1% and brimonidine tartrate 0.2% eye drops suspension bottle Australia - English - Department of Health (Therapeutic Goods Administration)

simbrinza 1%/0.2% brinzolamide 1% and brimonidine tartrate 0.2% eye drops suspension bottle

novartis pharmaceuticals australia pty ltd - brimonidine tartrate, quantity: 2 mg/ml; brinzolamide, quantity: 10 mg/ml - eye drops, suspension - excipient ingredients: propylene glycol; boric acid; mannitol; tyloxapol; sodium chloride; sodium hydroxide; purified water; carbomer 974p; hydrochloric acid; benzalkonium chloride - decrease of elevated intraocular pressure (iop) in adult patients with open-angle glaucoma or ocular hypertension for whom monotherapy provides insufficient iop reduction

ALPHAGAN P 1.5 brimonidine tartrate 0.15% eye drop bottle Australia - English - Department of Health (Therapeutic Goods Administration)

alphagan p 1.5 brimonidine tartrate 0.15% eye drop bottle

abbvie pty ltd - brimonidine tartrate, quantity: 1.5 mg/ml - eye drops, solution - excipient ingredients: magnesium chloride hexahydrate; boric acid; sodium chlorite; sodium chloride; carmellose sodium; borax; sodium hydroxide; purified water; hydrochloric acid; potassium chloride; calcium chloride dihydrate - alphagan p 1.5 eye drops are effective in lowering elevated intraocular pressure in patients with chronic open angle glaucoma or ocular hypertension. alphagan p 1.5 eye drops can be used in the treatment of glaucoma as either monotherapy or in combination with topical beta blockers.

COMBIGAN brimonidine tartrate 2.0mg/mL and timolol 5.0mg/mL eye drops bottle Australia - English - Department of Health (Therapeutic Goods Administration)

combigan brimonidine tartrate 2.0mg/ml and timolol 5.0mg/ml eye drops bottle

abbvie pty ltd - brimonidine tartrate, quantity: 2 mg/ml; timolol maleate, quantity: 6.8 mg/ml - eye drops, solution - excipient ingredients: benzalkonium chloride; dibasic sodium phosphate heptahydrate; monobasic sodium phosphate monohydrate; sodium hydroxide; purified water; hydrochloric acid - combigan eye drops are indicated for the reduction of elevated intraocular pressure for treatment of open angle glaucoma and/or ocular hypertension, in patients not adequately responding to monotherapy

ENIDIN brimonidine tartrate 2mg/mL eye drop bottle Australia - English - Department of Health (Therapeutic Goods Administration)

enidin brimonidine tartrate 2mg/ml eye drop bottle

abbvie pty ltd - brimonidine tartrate, quantity: 2 mg/ml - eye drops, solution - excipient ingredients: polyvinyl alcohol; benzalkonium chloride; citric acid; hydrochloric acid; sodium citrate dihydrate; sodium chloride; sodium hydroxide; purified water - indications:enidin eye drops are effective as monotherapy for lowering intraocular pressure in patients with chronic open-angle glaucoma or ocular hypertension in whom (beta symbol)-blockers are not tolerated or are contraindicated. indications as at 7 december 1999: enidin eye drops are effective in lowering elevated intraocular pressure in patients with chronic open angle glaucoma or ocular hypertension.enidin eye drops can be used in the treatment of glaucoma either as monotherapy or in combination with topical beta-blockers.

MIRVASO brimonidine 3.3 mg/g (as tartrate) gel tube Australia - English - Department of Health (Therapeutic Goods Administration)

mirvaso brimonidine 3.3 mg/g (as tartrate) gel tube

galderma australia pty ltd - brimonidine tartrate, quantity: 5 mg/g (equivalent: brimonidine, qty 3.3 mg/g) - gel - excipient ingredients: carbomer 974p; methyl hydroxybenzoate; phenoxyethanol; glycerol; titanium dioxide; propylene glycol; sodium hydroxide; purified water - mirvaso is indicated for the treatment of facial erythema of rosacea in adult patients

ENIDIN P 1.5 brimonidine tartrate 0.15% eye drop bottle Australia - English - Department of Health (Therapeutic Goods Administration)

enidin p 1.5 brimonidine tartrate 0.15% eye drop bottle

abbvie pty ltd - brimonidine tartrate, quantity: 1.5 mg/ml - eye drops, solution - excipient ingredients: sodium chloride; potassium chloride; borax; sodium hydroxide; sodium chlorite; purified water; calcium chloride dihydrate; boric acid; carmellose sodium; hydrochloric acid; magnesium chloride hexahydrate - enidin p 1.5 eye drops are effective in lowering elevated intraocular pressure in patients with chronic open angle glaucoma or ocular hypertension. enidin p 1.5 eye drops can be used in the treatment of glaucoma as either monotherapy or in combination with topical beta blockers.

ALPHAGAN Brimonidone tartrate 2mg/mL eye drop bottle Australia - English - Department of Health (Therapeutic Goods Administration)

alphagan brimonidone tartrate 2mg/ml eye drop bottle

abbvie pty ltd - brimonidine tartrate, quantity: 2 mg/ml - eye drops, solution - excipient ingredients: sodium hydroxide; purified water; sodium chloride; polyvinyl alcohol; citric acid; benzalkonium chloride; hydrochloric acid; sodium citrate dihydrate - indications: alphagan eye drops are effective as monotherapy for lowering intraocular pressure in patients with chronic open-angle glaucoma or ocular hypertension in whom (beta symbol)-blockers are not tolerated or are contraindicated. indications as at 7 december 1999: alphagan eye drops are effective in lowering elevated intraocular pressure in patients with chronic open angle glaucoma or ocular hypertension. alphagan eye drops can be used in the treatment of glaucoma either as monotherapy or in combination with topical beta-blockers.

BRIMONIDINE TARTRATE solution/ drops United States - English - NLM (National Library of Medicine)

brimonidine tartrate solution/ drops

regimed medical - brimonidine tartrate (unii: 4s9cl2dy2h) (brimonidine - unii:e6gnx3hhte) - brimonidine 2.0 mg in 1 ml - brimonidine tartrate ophthalmic solution is indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension. the iop lowering efficacy of brimonidine tartrate ophthalmic solution diminishes over time in some patients. this loss of effect appears with a variable time of onset in each patient and should be closely monitored. brimonidine tartrate ophthalmic solution is contraindicated in patients with hypersensitivity to brimonidine tartrate or any component of this medication. it is also contraindicated in patients receiving monoamine oxidase (mao) inhibitor therapy.

BRIMONIDINE TARTRATE solution/ drops United States - English - NLM (National Library of Medicine)

brimonidine tartrate solution/ drops

physicians total care, inc. - brimonidine tartrate (unii: 4s9cl2dy2h) (brimonidine - unii:e6gnx3hhte) - brimonidine tartrate 2 mg in 1 ml - brimonidine tartrate ophthalmic solution 0.2% is indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension. the lop lowering efficacy of brimonidine tartrate ophthalmic solution 0.2% diminishes over time in some patients. this loss of effect appears with a variable time of onset in each patient and should be closely monitored. brimonidine tartrate ophthalmic solution 0.2% is contraindicated in patients with hypersensitivity to brimonidine tartrate or any component of this medication. it is also contraindicated in patients receiving monoamine oxidase (mao) inhibitor therapy.

BRIMONIDINE TARTRATE solution United States - English - NLM (National Library of Medicine)

brimonidine tartrate solution

physicians total care, inc. - brimonidine tartrate (unii: 4s9cl2dy2h) (brimonidine - unii:e6gnx3hhte) - brimonidine tartrate 1.5 mg in 1 ml - brimonidine tartrate ophthalmic solution, 0.15% is indicated for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. brimonidine tartrate ophthalmic solution, 0.15% is contraindicated in patients with hypersensitivity to brimonidine tartrate or any component of this medication. it is also contraindicated in patients receiving monoamine oxidase (mao) inhibitor therapy.